flutiform 125 µg - 5 µg druckgasinhalation, suspension
mundipharma - fluticasone propionate; formoterolfumarat-dihydrat - druckgasinhalation, suspension - 125 µg - 5 µg - fluticasone propionate 125 µg; formoterolfumarat-dihydrat 5 µg - formoterol and fluticasone
flutiform 250 µg - 10 µg druckgasinhalation, suspension
mundipharma - fluticasone propionate; formoterolfumarat-dihydrat - druckgasinhalation, suspension - 250 µg - 10 µg - fluticasone propionate 0.25 mg; formoterolfumarat-dihydrat 0.01 mg - formoterol and fluticasone
flutiform k-haler 125 µg/dose - 5 µg/dose druckgasinhalation, suspension
mundipharma - fluticasone propionate; formoterolfumarat-dihydrat - druckgasinhalation, suspension - 125 µg/dose - 5 µg/dose - fluticasone propionate 0.125 mg/dose; formoterolfumarat-dihydrat 0.005 mg/dosis - formoterol and fluticasone
flutiform k-haler 50 µg/dose - 5 µg/dose druckgasinhalation, suspension
mundipharma - fluticasone propionate; formoterolfumarat-dihydrat - druckgasinhalation, suspension - 50 µg/dose - 5 µg/dose - fluticasone propionate 0.05 mg/dose; formoterolfumarat-dihydrat 0.005 mg/dosis - formoterol and fluticasone
inuvair 200 µg/dose - 6 µg/dose druckgasinhalation, lösung
chiesi - beclometasone dipropionate; formoterolfumarat-dihydrat - druckgasinhalation, lösung - 200 µg/dose - 6 µg/dose - beclometasone dipropionate 200 µg/dose; formoterolfumarat-dihydrat 6 µg/dosis - formoterol and beclometasone
inuvair nexthaler 100 µg/dose - 6 µg/dose pulver zur inhalation
chiesi - beclometasone dipropionate; formoterolfumarat-dihydrat - pulver zur inhalation - 100 µg/dose - 6 µg/dose - beclometasone dipropionate 100 µg/dose; formoterolfumarat-dihydrat 6 µg/dosis - formoterol and beclometasone
inuvair nexthaler 200 µg/dose - 6 µg/dose pulver zur inhalation
chiesi - beclometasone dipropionate; formoterolfumarat-dihydrat - pulver zur inhalation - 200 µg/dose - 6 µg/dose - beclometasone dipropionate 200 µg/dose; formoterolfumarat-dihydrat 6 µg/dosis - formoterol and beclometasone
symbicort 160 µg/dose - 4,5 µg/dose druckgasinhalation, suspension
astrazeneca - budesonid; formoterolfumarat-dihydrat - druckgasinhalation, suspension - 160 µg/dose - 4,5 µg/dose - budesonid 160 µg/dose; formoterolfumarat-dihydrat 4.5 µg/dosis - formoterol and budesonide
inuvair nexthaler 200 µg/dose - 12 µg/dose pulver zur inhalation
chiesi - beclometasone dipropionate; formoterolfumarat-dihydrat - pulver zur inhalation - 200 µg/dose - 12 µg/dose - beclometasone dipropionate 200 µg/dose; formoterolfumarat-dihydrat 12 µg/dosis - formoterol and beclometasone
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarat dihydrat, glycopyrronium bromide - lungenerkrankung, chronisch obstruktiv - medikamente für obstruktive atemwegserkrankungen, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.